journal article·2016-09Open access

Implantable amyloid hydrogels for promoting stem cell differentiation to neurons

Subhadeep Das, Kun Zhou, Dhiman Ghosh, Narendra N Jha, Pradeep K Singh, Reeba S Jacob, Claude C Bernard, David I Finkelstein, John S Forsythe, Samir K Maji

NPG Asia Materials· Volume 8· Issue 9

Abstract

We report a new class of amyloid-inspired peptide hydrogels that was designed and based on α-synuclein protein for which hydrogel formation is triggered by various stimuli, such as heating/cooling or changes in pH. The peptides resemble a cross-β-sheet-rich amyloid, and they assemble into a nanofibrous meshwork that mimics the natural extracellular matrix. Our design principle allows easy manipulation of the gelator sequence to exploit the desirable properties of amyloids for use in cell replacement therapies for neurodegenerative diseases. The amyloid hydrogels facilitate the attachment and neuronal differentiation of mesenchymal stem cells (MSCs) and assist in the delivery and engraftment of MSCs in the substantia nigra and caudate putamen of a Parkinsonian mouse model. A responsive, water-trapping biopolymer can fight neurodegenerative illnesses by promoting the growth and survival of implanted stem cells. Regenerating damaged portions of the nervous system with stem cells is a promising therapy for Alzheimer's and Parkinson's diseases, but ensuring cell viability in damaged brain tissue is challenging. Inspired by amyloid proteins that self-assemble into robust fibrils, Samir Maji from the Indian Institute of Technology in Mumbai, John Forsythe from Monash University in Melbourne and co-workers have developed peptide-based materials that turn into hydrogels on changing the pH or temperature. The hydrogels' nanofibrous, mesh-like structure and tunable stiffness proved favourable for cell replacement therapy. Experiments with Parkinsonian mouse models revealed that stem cells cultured on the hydrogels preferentially differentiated towards neurons and could be easily implanted thanks to the gels' ability to re-liquefy. Inspired by a popular self-assembled motif in proteins called amyloids, we have developed a series of hydrogels composed of amyloid nanofibrils. The gelation process could be induced via different stimuli, such as heating/cooling or change of pH. Human mesenchymal stem cells preferentially differentiate toward neurons when cultured on these hydrogels. Moreover, its shear thinning property facilitates transplantation of stem cells into the brain with minimally invasive surgery. We demonstrate here the utilization of injectable amyloid hydrogels, which promotes cell survival as well as neuronal differentiation in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Nerve injury and regeneration · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333–366 (2006).10.1146/annurev.biochem.75.101304.123901 ↗
2. Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M., Normark, S. & Hultgren, S. J. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295, 851–855 (2002).10.1126/science.1067484 ↗
3. Maji, S. K., Perrin, M. H., Sawaya, M. R., Jessberger, S., Vadodaria, K., Rissman, R. A., Singru, P. S., Nilsson, K. P., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W. & Riek, R. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325, 328–332 (2009).10.1126/science.1173155 ↗
4. Cherny, I. & Gazit, E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. 47, 4062–4069 (2008).10.1002/anie.200703133 ↗
5. Hamada, D., Yanagihara, I. & Tsumoto, K. Engineering amyloidogenicity towards the development of nanofibrillar materials. Trends Biotechnol. 22, 93–97 (2004).10.1016/j.tibtech.2003.12.003 ↗
6. Reynolds, N. P., Styan, K. E., Easton, C. D., Li, Y., Waddington, L., Lara, C., Forsythe, J. S., Mezzenga, R., Hartley, P. G. & Muir, B. W. Nanotopographic surfaces with defined surface chemistries from amyloid fibril networks can control cell attachment. Biomacromolecules 14, 2305–2316 (2013).10.1021/bm400430t ↗
7. Bongiovanni, M. N., Scanlon, D. B. & Gras, S. L. Functional fibrils derived from the peptide TTR1-cycloRGDfK that target cell adhesion and spreading. Biomaterials 32, 6099–6110 (2011).10.1016/j.biomaterials.2011.05.021 ↗
8. Mankar, S., Anoop, A., Sen, S. & Maji, S. K. Nanomaterials: amyloids reflect their brighter side. Nano Rev. (e-pub ahead of print 31 May 2011; doi:10.3402/nani.v2i0.6032).
9. Nelson, R. & Eisenberg, D. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 16, 260–265 (2006).10.1016/j.sbi.2006.03.007 ↗
10. Calamai, M., Kumita, J. R., Mifsud, J., Parrini, C., Ramazzotti, M., Ramponi, G., Taddei, N., Chiti, F. & Dobson, C. M. Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes. Biochemistry 45, 12806–12815 (2006).10.1021/bi0610653 ↗
11. Maji, S. K., Wang, L., Greenwald, J. & Riek, R. Structure-activity relationship of amyloid fibrils. FEBS Lett. 583, 2610–2617 (2009).10.1016/j.febslet.2009.07.003 ↗
12. Lindvall, O. & Kokaia, Z. Stem cells for the treatment of neurological disorders. Nature 441, 1094–1096 (2006).10.1038/nature04960 ↗
13. Mahoney, M. J. & Anseth, K. S. Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials 27, 2265–2274 (2005).10.1016/j.biomaterials.2005.11.007 ↗
14. Cooke, M. J., Vulic, K. & Shoichet, M. S. Design of biomaterials to enhance stem cell survival when transplanted into the damaged central nervous system. Soft Matter 6, 4988–4998 (2010).10.1039/c0sm00448k ↗
15. Tam, R. Y., Fuehrmann, T., Mitrousis, N. & Shoichet, M. S. Regenerative therapies for central nervous system diseases: a biomaterials approach. Neuropsychopharmacology 39, 169–188 (2014).10.1038/npp.2013.237 ↗
16. Reynolds, N. P., Charnley, M., Mezzenga, R. & Hartley, P. G. Engineered lysozyme amyloid fibril networks support cellular growth and spreading. Biomacromolecules 15, 599–608 (2014).10.1021/bm401646x ↗
17. Jacob, R. S., Ghosh, D., Singh, P. K., Basu, S. K., Jha, N. N., Das, S., Sukul, P. K., Patil, S., Sathaye, S., Kumar, A., Chowdhury, A., Malik, S., Sen, S. & Maji, S. K. Self healing hydrogels composed of amyloid nano fibrils for cell culture and stem cell differentiation. Biomaterials 54, 97–105 (2015).10.1016/j.biomaterials.2015.03.002 ↗
18. Gras, S. L., Tickler, A. K., Squires, A. M., Devlin, G. L., Horton, M. A., Dobson, C. M. & MacPhee, C. E. Functionalised amyloid fibrils for roles in cell adhesion. Biomaterials 29, 1553–1562 (2008).10.1016/j.biomaterials.2007.11.028 ↗
19. Li, C., Born, A. K., Schweizer, T., Zenobi-Wong, M., Cerruti, M. & Mezzenga, R. Amyloid-hydroxyapatite bone biomimetic composites. Adv. Mater. 26, 3207–3212 (2014).10.1002/adma.201306198 ↗
20. Volles, M. J. & Lansbury, P. T. Relationships between the sequence of α-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 366, 1510–1522 (2007).10.1016/j.jmb.2006.12.044 ↗
21. Ghosh, D. & Maji, S. K. Preparation of aggregate-free α -synuclein for in vitro aggregation study. Protoc. Exchange, doi:10.1038/protex.2015.037 (2015).10.1038/protex.2015.037 ↗
22. Giehm, L. & Otzen, D. E. Strategies to increase the reproducibility of protein fibrillization in plate reader assays. Anal. Biochem. 400, 270–281 (2010).10.1016/j.ab.2010.02.001 ↗
23. Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Olieric, V., Böckmann, A., Meier, B. H. & Melki, R. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).10.1038/ncomms3575 ↗
24. Singh, P. K., Kotia, V., Ghosh, D., Mohite, G. M., Kumar, A. & Maji, S. K. Curcumin modulates α-synuclein aggregation and toxicity. ACS Chem. Neurosci. 4, 393–407 (2012).10.1021/cn3001203 ↗
25. Smith, A. M., Williams, R. J., Tang, C., Coppo, P., Collins, R. F., Turner, M. L., Saiani, A. & Ulijn, R. V. Fmoc-diphenylalanine self assembles to a hydrogel via a novel architecture based on π-π interlocked β-sheets. Adv. Mater. 20, 37–41 (2008).10.1002/adma.200701221 ↗
26. LeVine, H. 3rd Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274–284 (1999).10.1016/S0076-6879(99)09020-5 ↗
27. Sunde, M. & Blake, C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein. Chem. 50, 123–159 (1997).10.1016/S0065-3233(08)60320-4 ↗
28. Jackson, M. & Mantsch, H. H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95–120 (1995).10.3109/10409239509085140 ↗
29. Selkoe, D. J. Folding proteins in fatal ways. Nature 426, 900–904 (2003).10.1038/nature02264 ↗
30. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).10.1016/0022-1759(83)90303-4 ↗
31. Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M. & Biere, A. L. α-Synuclein fibrillogenesis is nucleation-dependent: implications for the pathogenesis of Parkinson’s disease. J. Biol. Chem. 274, 19509–19512 (1999).10.1074/jbc.274.28.19509 ↗
32. Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318–1320 (1998).10.1038/3311 ↗
33. Breydo, L., Wu, J. W. & Uversky, V. N. α-Synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta 1822, 261–285 (2012).10.1016/j.bbadis.2011.10.002 ↗
34. Willander, H., Presto, J., Askarieh, G., Biverstål, H., Frohm, B., Knight, S. D., Johansson, J. & Linse, S. BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J. Biol. Chem. 287, 31608–31617 (2012).10.1074/jbc.M112.393157 ↗
35. Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689 (2006).10.1016/j.cell.2006.06.044 ↗
36. Khoo, M. L. M., Tao, H., Meedeniya, A. C. B., Mackay-Sim, A. & Ma, D. D. F. Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents. PLoS One 6, e19025 (2011).10.1371/journal.pone.0019025 ↗
37. Trzaska, K. A., Kuzhikandathil, E. V. & Rameshwar, P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 25, 2797–2808 (2007).10.1634/stemcells.2007-0212 ↗
38. Danzer, K. M., Haasen, D., Karow, A. R., Moussaud, S., Habeck, M., Giese, A., Kretzschmar, H., Hengerer, B. & Kostka, M. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220–9232 (2007).10.1523/JNEUROSCI.2617-07.2007 ↗
39. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., Tzitzilonis, C., Soragni, A., Jessberger, S., Mira, H., Consiglio, A., Pham, E., Masliah, E., Gage, F. H. & Riek, R. In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. 108, 4194–4199 (2011).10.1073/pnas.1100976108 ↗
40. Jacob, R. S., Das, S., Ghosh, D. & Maji, S. K. Influence of retinoic acid on mesenchymal stem cell differentiation in amyloid hydrogels. Data Brief 5, 954–958 (2015).10.1016/j.dib.2015.11.015 ↗
41. Hersel, U., Dahmen, C. & Kessler, H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24, 4385–4415 (2003).10.1016/S0142-9612(03)00343-0 ↗
42. Tashiro, K., Sephel, G. C., Weeks, B., Sasaki, M., Martin, G. R., Kleinman, H. K. & Yamada, Y. A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. J. Biol. Chem. 264, 16174–16182 (1989).10.1016/S0021-9258(18)71604-9 ↗
43. Jacob, R. S., George, E., Singh, P. K., Salot, S., Anoop, A., Jha, N. N., Sen, S. & Maji, S. K. Cell adhesion on amyloid fibrils lacking integrin recognition motif. J. Biol. Chem. 291, 5278–5298 (2016).10.1074/jbc.M115.678177 ↗
44. Discher, D. E., Mooney, D. J. & Zandstra, P. W. Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673–1677 (2009).10.1126/science.1171643 ↗
45. Reilly, G. C. & Engler, A. J. Intrinsic extracellular matrix properties regulate stem cell differentiation. J. Biomech. 43, 55–62 (2010).10.1016/j.jbiomech.2009.09.009 ↗
46. Teo, B. K., Wong, S. T., Lim, C. K., Kung, T. Y., Yap, C. H., Ramagopal, Y., Romer, L. H. & Yim, E. K. Nanotopography modulates mechanotransduction of stem cells and induces differentiation through focal adhesion kinase. ACS Nano 7, 4785–4798 (2013).10.1021/nn304966z ↗
47. Wang, Y.-K. & Chen, C. S. Cell adhesion and mechanical stimulation in the regulation of mesenchymal stem cell differentiation. J. Cell. Mol. Med. 17, 823–832 (2013).10.1111/jcmm.12061 ↗
48. Wen, J. H., Vincent, L. G., Fuhrmann, A., Choi, Y. S., Hribar, K. C., Taylor-Weiner, H., Chen, S. & Engler, A. J. Interplay of matrix stiffness and protein tethering in stem cell differentiation. Nat. Mater. 13, 979–987 (2014).10.1038/nmat4051 ↗
49. Nisbet, D. R., Rodda, A. E., Horne, M. K., Forsythe, J. S. & Finkelstein, D. I. Neurite infiltration and cellular response to electrospun polycaprolactone scaffolds implanted into the brain. Biomaterials 30, 4573–4580 (2009).10.1016/j.biomaterials.2009.05.011 ↗
50. Crompton, K. E., Tomas, D., Finkelstein, D. I., Marr, M., Forsythe, J. S. & Horne, M. K. Inflammatory response on injection of chitosan/GP to the brain. J. Mater. Sci. Mater. Med. 17, 633–639 (2006).10.1007/s10856-006-9226-6 ↗
51. Ritter, M. R., Banin, E., Moreno, S. K., Aguilar, E., Dorrell, M. I. & Friedlander, M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 116, 3266–3276 (2006).10.1172/JCI29683 ↗
52. Malgosia, M. P., Brian, G. B. & Molly, S. S. Injectable hydrogels for central nervous system therapy. Biomed. Mater. 7, 024101 (2012).10.1088/1748-6041/7/2/024101 ↗
53. Walker, P. A., Shah, S. K., Harting, M. T. & Cox, C. S. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis. Model Mech. 2, 23–38 (2009).10.1242/dmm.001198 ↗
54. Nakaji-Hirabayashi, T., Kato, K. & Iwata, H. In vivo study on the survival of neural stem cells transplanted into the rat brain with a collagen hydrogel that incorporates laminin-derived polypeptides. Bioconjug. Chem. 24, 1798–1804 (2013).10.1021/bc400005m ↗
55. Giordano, C., Albani, D., Gloria, A., Tunesi, M., Batelli, S., Russo, T., Forloni, G., Ambrosio, L. & Cigada, A. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies. Int. J. Artif. Organs 32, 836–850 (2009).10.1177/039139880903201202 ↗
56. Zhong, J., Chan, A., Morad, L., Kornblum, H. I., Fan, G. & Carmichael, S. T. Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil. Neural Repair 24, 636–644 (2010).10.1177/1545968310361958 ↗
57. Li, D., Jones, E. M., Sawaya, M. R.,. Furukawa, H., Luo, F., Ivanova, M., Sievers, S. A., Wang, W., Yaghi, O. M., Liu, C. & Eisenberg, D. S. Structure-based design of functional amyloid materials. J. Am. Chem. Soc. 136, 18044–18051 (2014).10.1021/ja509648u ↗